organization · Reporting owner
Complete Pharma Holdings II, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PTC THERAPEUTICS, INC.
Report date April 28, 2017 · Filed May 03, 2017
Section 16 reporting ended · disclosed 2017-05-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 1
1 source rowRow 1 · 2017-04-28 · Other · Disposed 6,683,598 · Balance 0 F1: Pro rata distribution of such common stock to those members of the reporting person that are "accredited investors" as defined in Regulation D promulgated under the Securities Act of 1933, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution of such common stock to those members of the reporting person that are "accredited investors" as defined in Regulation D promulgated under the Securities Act of 1933, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2017 Filed May 3, 2017 00:09 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | OtherCommon Stock | 6,683,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-17-000733 · e616090_4-ptc.xml · nonDerivative · entry 1 Complete Pharma Holdings II, LLC · CIK 0001704768 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pro rata distribution of such common stock to those members of the reporting person that are "accredited investors" as defined in Regulation D promulgated under the Securities Act of 1933, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.